Belite Bio Inc ADR (BLTE) had the highest return between June 10, 2022 and June 30, 2022 by a mid-cap US stock, returning 87.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Belite Bio Inc ADR (BLTE) | 6/10/2022 - 6/30/2022 | 87.93% |
Axsome Therapeutics (AXSM) | 6/10/2022 - 6/30/2022 | 51.32% |
PTC Therapeutics (PTCT) | 6/10/2022 - 6/30/2022 | 47.44% |
Wave Life Sciences (WVE) | 6/10/2022 - 6/30/2022 | 45.74% |
Nuvalent (NUVL) | 6/10/2022 - 6/30/2022 | 42.29% |
Praxis Precision Medicines (PRAX) | 6/10/2022 - 6/30/2022 | 40% |
Cogent Biosciences (COGT) | 6/10/2022 - 6/30/2022 | 36.67% |
Centessa Pharmaceuticals PLC ADR (CNTA) | 6/10/2022 - 6/30/2022 | 33.79% |
Miniso Group Holding (MNSO) | 6/10/2022 - 6/30/2022 | 32.38% |
Dyne Therapeutics (DYN) | 6/10/2022 - 6/30/2022 | 31.61% |
Viking Therapeutics (VKTX) | 6/10/2022 - 6/30/2022 | 30.18% |
Amicus Therapeutics (FOLD) | 6/10/2022 - 6/30/2022 | 28.78% |
Kymera Therapeutics (KYMR) | 6/10/2022 - 6/30/2022 | 24.94% |
New Oriental Education & Technology (EDU) | 6/10/2022 - 6/30/2022 | 24.07% |
Edgewise Therapeutics (EWTX) | 6/10/2022 - 6/30/2022 | 23.79% |
Denali Therapeutics (DNLI) | 6/10/2022 - 6/30/2022 | 23.76% |
Terns Pharmaceuticals (TERN) | 6/10/2022 - 6/30/2022 | 22.77% |
HUTCHMED DRC (HCM) | 6/10/2022 - 6/30/2022 | 22.48% |
Celcuity LLC (CELC) | 6/10/2022 - 6/30/2022 | 22.15% |
Legend Biotech (LEGN) | 6/10/2022 - 6/30/2022 | 21.47% |
Veracyte (VCYT) | 6/10/2022 - 6/30/2022 | 20.53% |
TransMedics (TMDX) | 6/10/2022 - 6/30/2022 | 19.58% |
ELF Beauty (ELF) | 6/10/2022 - 6/30/2022 | 19.42% |
Daqo New Energy Corp ADR (DQ) | 6/10/2022 - 6/30/2022 | 18.97% |
Ultragenyx (RARE) | 6/10/2022 - 6/30/2022 | 18.8% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
